Mead Johnson Nutrition Company today said that it has closed its previously announced initial public offering of 30 million shares of Class A common stock at the public offering price of $24 per share. Further, the underwriters of the offering have exercised their over-allotment option and purchased 4.5 million additional shares of Class A common stock.
Including the over-allotment, the Company sold 34.5 million shares in the offering for net proceeds of approximately $782 million, after deducting underwriting discounts, commissions and estimated offering expenses. The Company said that with this over-allotment, it will have 204.5 million shares of Class A and Class B common stock outstanding.
Citi, Morgan Stanley, Banc of America Securities LLC, Credit Suisse and J.P. Morgan acted as joint book-running managers for the offering. A copy of the final prospectus relating to the offering can be obtained from:
-- Citigroup Global Markets Inc., Brooklyn Army Terminal, 140 58th Street, 8th Floor, Brooklyn, New York 11220, Attention: Prospectus Department, telephone (800) 831-9146, or by emailing [email protected].
-- Morgan Stanley & Co. Incorporated, 180 Varick Street, 2nd Floor, New York, New York 10014, Attention: Prospectus Department, telephone (866) 718-1649, or by emailing [email protected].
About Mead Johnson
Mead Johnson develops, manufactures, markets and distributes more than 70 products in 50 markets worldwide primarily under the "Enfa" family of brands, including Enfamil(R) infant formula. For more information on Mead Johnson go to www.meadjohnson.com.